SS Innovations announced today that it filled the first international order for its SSi Mantra surgical robot platform.
Fort Lauderdale, Florida-based SS Innovations delivered the unit to Aster Hospital in Dubai, United Arab Emirates. Aster DM Healthcare Limited — which operates 32 hospitals and other healthcare facilities in six countries — part-operates that hospital.
Designed to support advanced, affordable and accessible robotic surgery, SSi Mantra provides capabilities for multi-specialty uses. Its uses span cardiothoracic, head and neck, gynecology, urology, general surgery and more. The system features a modular, 3D vision, open-console design with superior ergonomics. It engages machine learning models to improve safety and efficiency during procedures.
News of the sale follows the company’s announcement last week that began work on regulatory submissions for SSi Mantra. SS Innovations already received regulatory approval from Indian authorities and validated the system in more than 40 different procedures. The United Arab Emirates Ministry of Health also granted approval for import into the UAE for clinical use. It now seeks FDA approval and CE mark.
“We are grateful to Aster DM Healthcare for acquiring the first SSi Mantra system in the region, which will be placed at their Aster Hospital in Dubai,” said Dr. Sudhir Srivastava, CEO, chair and founder of SS Innovations. “This will allow patients from the entire region to seek out the cost-effective and gold-standard surgical care that the SSi Mantra delivers.”